Restricted or absent immune responses in human populations to Plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies.
about
The novel putative transporter NPT1 plays a critical role in early stages of Plasmodium berghei sexual developmentDifferential ability of specific regions of Plasmodium falciparum sexual-stage antigen, Pfs230, to induce malaria transmission-blocking immunityThe IC(50) of anti-Pfs25 antibody in membrane-feeding assay varies among species.Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and eliminationGeneralized immunological recognition of the major merozoite surface antigen (gp195) of Plasmodium falciparum.Current developments in malaria transmission-blocking vaccines.N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity.Pfs230: from malaria transmission-blocking vaccine candidate toward function.Leukocytes in a Plasmodium falciparum-infected blood meal reduce transmission of malaria to Anopheles mosquitoes.Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25.Naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs48/45 and Pfs230 in an area of seasonal transmissionDoes malaria suffer from lack of memory?Plasmodium p25 and p28 surface proteins: potential transmission-blocking vaccines.Plasmodium falciparum Gametocyte-Specific Antibody Profiling Reveals Boosting through Natural Infection and Identifies Potential Markers of Gametocyte Exposure.Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations.Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25, a Plasmodium falciparum transmission-blocking vaccine antigen.Adjuvant-dependent immune response to malarial transmission-blocking vaccine candidate antigens.Pfs2400 can mediate antibody-dependent malaria transmission inhibition and may be the Plasmodium falciparum 11.1 gene productAnti-Pfs25 human plasma reduces transmission of Plasmodium falciparum isolates that have diverse genetic backgroundsVaccines against malaria - an update.Analysis of immunity induced by the affinity-purified 21-kilodalton zygote-ookinete surface antigen of Plasmodium bergheiPlasmodium falciparum genotype and gametocyte prevalence in children with uncomplicated malaria in coastal Ghana.Identification of a continuous and cross-reacting epitope for Plasmodium falciparum transmission-blocking immunity.Application of wheat germ cell-free protein expression system for novel malaria vaccine candidate discovery.Associations Between Helminth Infections, Plasmodium falciparum Parasite Carriage and Antibody Responses to Sexual and Asexual Stage Malarial Antigens.Parasite infectivity and immunity to Plasmodium falciparum gametocytes in Gambian children.The primary antibody response of malaria patients to Plasmodium falciparum sexual stage antigens which are potential transmission blocking vaccine candidates.Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230.The biology of malarial parasite in the mosquito--a review.Heat-precipitation allows the efficient purification of a functional plant-derived malaria transmission-blocking vaccine candidate fusion protein.The biology of Plasmodium falciparum transmission stages.Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing.Human immune recognition of recombinant proteins representing discrete domains of the Plasmodium falciparum gamete surface protein, Pfs230.Plasmodium falciparum malaria transmission-blocking immunity under conditions of low endemicity as in Sri Lanka.Immunogenicity of malaria transmission-blocking vaccine candidate, y230.CA14 following crosslinking in the presence of tetanus toxoid.Identification of a peptide sequence of the 25 kD surface protein of Plasmodium falciparum recognized by transmission-blocking monoclonal antibodies: implications for synthetic vaccine development.The P25 Ookinete Surface Proteins: Homology Modeling and Phylogenetic Relationships
P2860
Q30041784-8863D95B-703C-4013-98BD-5BE97A6B608FQ30042993-4E92FE5D-2401-4D9F-A92E-8C8F8B839D9CQ33892507-1C3AEEB9-9922-48D6-8990-FE813E67F1C7Q34177472-C633F907-0A71-4230-87F9-A6FCA65C429EQ34298109-2C03B548-87E2-4E32-BA80-0DFAECACFB7EQ34451883-15D6F30F-D971-46EB-A4B1-4BA0CBBDCAB8Q35138720-0C9BC07F-10D0-4560-9F29-2C2E88D91B63Q35548285-CC40F6BD-CF70-4C4A-A317-2882486D6590Q35555477-1BA37C7F-8A48-44AB-95FD-B9E154C9271FQ35575993-F8FEB703-1D0B-4829-8E24-BDF424773B51Q35598030-26CBFEDD-E995-43CD-80AC-C50973969D11Q35884250-A2C70885-D9E6-45ED-BA1D-3C93493C7221Q35947113-BC522E96-3D31-49EF-8D8D-6BF98D72E105Q36138015-DE8A90D0-D15E-4815-8434-852909CDE1F0Q36228933-AA35D0DB-C000-4BB4-B729-2CD0BFDC1119Q36228960-50E7A8A4-19E2-40A2-B2FB-5CBE88055F8DQ36231958-CF88D46C-16F2-4574-83D3-D1BA2995CB0DQ36361341-AF31EC72-9A7D-4759-A4E1-886ECDE26CA8Q36911492-3475DBE0-8B83-4762-9947-8AE82DD9B21FQ36933780-B8A794E7-1269-40B2-95C5-3DF44CFF5C98Q36958620-4C109D74-E229-43A5-B81F-A066582E4BF9Q37491136-B4C20C9D-FA4D-49C8-B648-14ACBE3A6826Q37611409-FB606067-AF2E-4AD8-8BF1-2BAF47122A34Q38168906-6B4DF143-FE39-4959-B166-31FAE958B510Q38882835-0F07EBE9-2604-45B4-85BE-AB83677A5D2AQ38977779-603DC856-8EA5-4D8A-BA96-887A08C976B5Q39324954-64186A6F-0459-4ACE-ACA2-BE58D264064EQ39830524-88A61066-B1A5-4EC4-A608-E09F60BCF83AQ41460217-A604D8FC-275A-48B8-AF29-17F3FBEE8336Q41525140-88D4F0DF-4160-437D-BA77-55F510422A89Q44139370-5397B346-84B7-4F53-8E4B-785AB1773F43Q44168384-E76E30E0-A9B9-4285-96B4-342E8AC98AA8Q44169334-E46A4E9D-7058-4FF7-9D29-A37E042DF822Q44170313-96900446-2F29-4073-945E-A1F9D924FA56Q47856385-1C4D2CD5-2373-4497-A308-F862D6A1FD59Q47894291-F4026928-C0F9-49D3-988D-E949C5CDE2CDQ58995298-4AD603FF-5E2A-4DA4-8CFF-E79394B6F0FB
P2860
Restricted or absent immune responses in human populations to Plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Restricted or absent immune re ...... nsmission-blocking antibodies.
@ast
Restricted or absent immune re ...... nsmission-blocking antibodies.
@en
type
label
Restricted or absent immune re ...... nsmission-blocking antibodies.
@ast
Restricted or absent immune re ...... nsmission-blocking antibodies.
@en
prefLabel
Restricted or absent immune re ...... nsmission-blocking antibodies.
@ast
Restricted or absent immune re ...... nsmission-blocking antibodies.
@en
P2860
P50
P921
P356
P1476
Restricted or absent immune re ...... nsmission-blocking antibodies.
@en
P2093
P2860
P304
P356
10.1084/JEM.169.1.135
P407
P577
1989-01-01T00:00:00Z